Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia

Brain Research

Volumn 796, Issue 1-2, 1998, Pages 291-295

  Hamid, Emad H ^a   Hyde, Thomas M ^a   Baca, Serapio M ^a   Egan, Michael F ^a  

^a Neurosci Res Ctr Natl I   (United States)

Author keywords

Haloperidol; NMDA receptor; Nucleus accumbens; Receptor autoradiography; Striatum; Tardive dyskinesia; Vacuous chewing movements' syndrome

Indexed keywords

DIZOCILPINE; HALOPERIDOL DECANOATE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DYSKINESIA; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; TARDIVE DYSKINESIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; CORPUS STRIATUM; DIZOCILPINE MALEATE; DOWN-REGULATION; DYSKINESIA, DRUG-INDUCED; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; MALE; MASTICATION; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SYNAPTIC TRANSMISSION;

EID: 0032526871     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00196-6     Document Type: Article

References (23)

1. 3H ]-MK-801 binding sites in mammalian brian Br. J. Pharmacol. 93:1988;944-954.
2. Bronstein D.M., Ye H., Pennypacker K.R., Hudson P.M., Hong J.-S. Role of a 35 kDa fos-related antigen (FRA) in the long-term induction of striatal dynorphin expression in the 6-hydroxydopamine lesioned rat. Mol. Brain Res. 23:1994;191-203.
3. Carlsson M., Carlsson A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13:1990;272-276.
4. Desce J.M., Godeheu G., Galli T., Artaud F., Cheramy A., Glowinski J. L-glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339.
5. Deutch A.Y. Prefrontal cortical dopamine systems and elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. J. Neural Transm. [GenSect]. 91:1993;197-221.
6. Deutch A.Y., Moghaddam B., Innis R.B., Krystal J.H., Aghajanian G.K., Bunney B.S., Charney D.S. Mechanisms of action of atypical antipsychotic drugs: implications for novel therapeutic strategies for schizophrenia. Schizophr. Res. 4:1991;121-156.
7. Egan M.F., Hurd Y., Hyde T.M., Weinberger D.R., Wyatt R.J., Kleinman J.E. Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias. Synapse. 18:1994;178-189.
8. Egan M.F., Hurd Y., Ferguson J., Bachus S.E., Hamid E.H., Hyde T.M. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology. 127:1996;337-345.
9. V. Khot, M.F. Egan, T.M. Hyde, R.J. Wyatt, Neuroleptics and classic tardive dyskinesia, in: L.A. E., W.J. Weiner (Eds.), Drug-Induced Movement Disorders, Vol. 5, Futura Publishing, Mount Kisco, NY, 1992, pp. 121-166.
10. 3H ]acetylcholine from rat striatal slices Brain Res. 252:1982;77-89.
11. Martinez-Fong D., Rosales M.G., Gongora-Alfaro J.L., Hernandez S., Aceves J. NMDA receptor mediates dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res. 595:1992;309-315.
12. Meshul C.K., Stallbaumer R.K., Taylor B., Janowsky A. Haloperidol-induced morphological changes in striatum are associated with glutamate synapse. Brain Res. 648:1994;181-195.
13. Meshul C.K., Bunker G.L., Mason J.N., Allen C., Janowsky A. Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses. J. Neurochem. 67:1996;1965-1973.
14. 3H ]-glutamic acid release by dopaminergic drugs Life Sci. 26:1980;2073-2081.
15. G. Paxinos, C. Watson, The Rat Brain Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
16. Pin J.P., Van-Vliet B.J., Bockaert J. NMDA- and kainate-evoked GABA release from striatal neurons differentiated in primary culture: differential blocking by phencyclidine. Neurosci. Lett. 87:1988;87-92.
17. Sandor N.T., Brassai A., Puskas A., Lendvai B. Role of nitric oxide in modulating neurotransmitter release from rat striatum. Brain Res. Bull. 36:1994;483-486.
18. Schwarcz R., Creese I., Coyle J.T., Snyder S.H. Dopamine receptors localized on cerebral afferents to rat corpus striatum. Nature. 271:1978;766-768.
19. See R.E., Chapman M.A. Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur. J. Pharm. 263:1994;269-276.
20. See R.E., Chapman M.A., Meshul C.K. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse. 12:1992;147-154.
21. Singh N.A., Midgley L.P., Bush L.G., Gibb J.W., Hanson G.R. N-methyl-D-aspartate receptors mediate dopamine-induced changes in extrapyramidal and limbic dynorphin systems. Brain Res. 555:1991;233-238.
22. Somers D.L., Beckstead R.M. N-methyl-D-aspartate receptor antagonism alters substance P and met 5-enkephalin biosynthesis in neurons of the rat striatum. J. Pharmacol. Exp. Ther. 262:1992;823-833.
23. Yamamoto B.K., Cooperman M.A. Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14:1994;4159-4166.